Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial
NCT06926062 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1900
Last updated 2026-03-13
Summary
This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for human papillomavirus (HPV) and other vaccinations in pharmacies. Low HPV vaccination in the United States has placed unvaccinated children at risk of developing cancers as adults that could have been prevented. Pharmacies can be convenient for vaccination because they are open longer hours, have shorter wait times, can see patients without appointments and may cost less. However, many people are not aware that vaccination is available in pharmacies and some pharmacies lack the commitment from staff to vaccinate or may not have protocols in place for vaccination. Proactive communication approaches to recommending HPV vaccination have been shown to be effective in medical offices but have not been tested in the pharmacy setting. Interpersonal communication training incorporates the 5 A's (assess, advice, agree, assist and arrange) behavioral counseling framework to strongly recommend HPV and other vaccines and effectively answer any questions or concerns about vaccination. Vaccination workflow training establishes vaccination decision support strategies that pharmacies use to improve vaccination workflows. Interpersonal communication training and vaccination workflow training alone or in combination may improve communication and recommendations for HPV vaccination and increase HPV vaccination in pharmacies.
Conditions
- Human Papillomavirus-Related Carcinoma
Interventions
- OTHER
-
Best Practice
Provide vaccinations per usual care
- OTHER
-
Educational Intervention
Review messages on safety and side effects
- OTHER
-
Educational Intervention
Review messages on vaccine effectiveness
- OTHER
-
Educational Intervention
Review messages on sexual activity
- OTHER
-
Educational Intervention
Review messages on HPV vaccine for boys
- OTHER
-
Educational Intervention
Review message on age to start vaccine
- OTHER
-
Educational Intervention
Review messages on school entry requirements
- OTHER
-
Interview
Ancillary studies
- OTHER
-
Questionnaire Administration
Complete a survey
- OTHER
-
Questionnaire Administration
Ancillary studies
- BEHAVIORAL
-
Training and Education
Receive interpersonal communication training
- BEHAVIORAL
-
Training and Education
Receive the vaccination workflow training
- PROCEDURE
-
Vaccination
Provide vaccinations using the interpersonal communication strategy
- PROCEDURE
-
Vaccination
Provide vaccinations using the vaccination workflow training strategy
- PROCEDURE
-
Vaccination
Provide vaccinations using both the interpersonal communication strategy and the vaccination workflow training strategy
Sponsors & Collaborators
- collaborator INDUSTRY
-
Fred Hutchinson Cancer Center
lead OTHER
Principal Investigators
-
Parth Shah, PharmD, PhD · Fred Hutch/University of Washington Cancer Consortium
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2026-09-01
- Completion
- 2027-10-01
Countries
- United States
Study Locations
More Related Trials
-
The STOP-HPV Trial 4: Bundle Intervention
NCT03609242 ·Status: UNKNOWN ·Phase: NA
-
Intradermal, Fractional Dose of HPV Vaccines:
NCT04235257 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Adolescent Vaccination in Pharmacies
NCT01960088 ·Status: COMPLETED
-
Communication Strategies to Increase HPV Vaccination Intention
NCT06784960 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
Immunogenicity of Fractional Dose of the HPV Vaccines
NCT05291871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
NCT00365443 ·Status: WITHDRAWN ·Phase: PHASE2
-
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
NCT00572832 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
NCT03599570 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
NCT06007092 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Tailoring of Vaccine-Focused Messages: Disease Salience
NCT03002324 ·Status: COMPLETED ·Phase: NA
-
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
NCT03759236 ·Status: COMPLETED ·Phase: NA
-
Can an Educational Intervention Targeting General Practitioners Increase HPV Vaccination Coverage in AuRA_Lyon (France)
NCT03592225 ·Status: UNKNOWN ·Phase: NA
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle
NCT03609372 ·Status: WITHDRAWN ·Phase: NA
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
NCT01526551 ·Status: COMPLETED ·Phase: NA
-
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination
NCT03350698 ·Status: UNKNOWN ·Phase: PHASE4
-
PREVENT HPV -Related Cancers Trial
NCT07217145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
NCT02888418 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
NCT01984697 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting
NCT01184079 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885 ·Status: COMPLETED ·Phase: NA